You are right maysgr the valuation is effective till 30/9 and only accounts for the cash statement till 30/6 in the balance sheet
which is all they have to use.
My contingency plan to this would be to hopefully drag this out so that the court appointed date wouldnt be before the half yearly accounts would be due and finalised (mid-late Feb I believe)and hence our grounds for unfair price is that we have another six months income on the balance sheet and therefore request the new IER be based on those figures as this directly affects the valuation!
That would definetely increase the price and the court would reject their offer.
Does this seem a feasable outcome?
Regards
smartchemist
RRP Price at posting:
8.5¢ Sentiment: Hold Disclosure: Held